3-Methyl-4-methylthiophenol

We are 3-Methyl-4-methylthiophenol CAS:3120-74-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 3120-74-9
Product Name: 3-Methyl-4-methylthiophenol
Other Name:
3-Methyl-4-methylthiophenol
4-(Methylsulfanyl)-m-cresol
3-Methyl-4-(methylsulfanyl)phenol
Methylthiomethylphenol
 
Density: 1.2±0.1 g/cm3
Boiling Point: 263.5±33.0 °C at 760 mmHg
Melting Point: 56-60°C
Molecular Formula: C8H10OS
Molecular Weight: 154.229
Flash Point: 128.7±24.1 °C
Exact Mass: 154.045242
PSA: 45.53000
LogP: 2.27
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Index of Refraction: 1.597
 
Specification
Appearance: Colorless needle crystal
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Fenamiphos CAS: 22224-92-6.
Intermediates of Fenthion CAS: 55-38-9.
Be used as pesticide intermediate, mainly used in the synthesis insecticide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Methyl-4-methylthiophenol


Related News: Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”2-bromo-N-methyl-N-(4-nitrophenyl)acetamide At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.N4,N4,N4'-Triphenyl-[1,1'-biphenyl]-4,4'-diamine Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.cyclohexane-1,3-dione Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.

Related Products
Product Name
METHYLTRI-N-PROPOXYSILANE View Details
N-(5-chloro(2-pyridyl)){2-[(4-cyanophenyl)carbonylamino]-5-methoxyphenyl}-carboxamide View Details
N-Ethylethylenediamine View Details
somatorelin manufacturer N-Boc-(3S)-3-phenyl-3-aminopropionaldehyde manufacturer Bis(2,6-difluoro-3-(1-hydropyrrol-1-yl)phenyl)titanocene manufacturer (1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate manufacturer 6-bromo-7H-purine manufacturer